Personal information

Denmark

Activities

Employment (2)

Herlev Hospital: Herlev, DK

2022-03-01 to present | Specialist Medical Training Program in Gastroenterology and Hepatology (Gastroenterology and hepatology)
Employment
Source: Self-asserted source
Mads Israelsen

Odense University Hospital: Odense, Region of Souther Denmark, DK

2020-10-01 to present | Post Doc (Deparment of Gastroenterology and Hepatology)
Employment
Source: Self-asserted source
Mads Israelsen

Education and qualifications (2)

University of Southern Denmark: Odense, Syddanmark, DK

2020 | PhD ( Department of Clinical Research)
Qualification
Source: Self-asserted source
Mads Israelsen

University of Copenhagen: Copenhagen, DK

2009-09-01 to 2016-11-01 | Medical Doctor (Faculty of health and medical science)
Education
Source: Self-asserted source
Mads Israelsen

Works (39)

Noninvasive assessment of hepatic decompensation

Hepatology
2025-03 | Journal article
Contributors: Maja Thiele; Stine Johansen; Mads Israelsen; Jonel Trebicka; Juan G. Abraldes; Pere Gines; Aleksander Krag
Source: check_circle
Crossref

State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus

The Lancet Microbe
2025-02 | Journal article
Contributors: Julie Rodriguez; Zahra Hassani; Carolina Alves Costa Silva; Fay Betsou; Federica Carraturo; Alessio Fasano; Mads Israelsen; Anandhi Iyappan; Aleksander Krag; Amira Metwaly et al.
Source: check_circle
Crossref

Non-invasive tests for alcohol-associated liver disease

Hepatology
2024-12 | Journal article
Contributors: Mads Israelsen; Wiramon Rungratanawanich; Maja Thiele; Suthat Liangpunsakul
Source: check_circle
Crossref

The steatotic liver disease burden paradox: unravelling the key role of alcohol

Nature Reviews Gastroenterology & Hepatology
2024-12-05 | Journal article
Contributors: Nikolaj Torp; Mads Israelsen; Aleksander Krag
Source: check_circle
Crossref

Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists

Hepatology Communications
2024-11 | Journal article
Contributors: Ellen L. Jensen; Mads Israelsen; Aleksander Krag
Source: check_circle
Crossref

Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases

Journal of Hepatology
2024-08 | Journal article
Contributors: Maja Thiele; Ida Falk Villesen; Lili Niu; Stine Johansen; Karolina Sulek; Suguru Nishijima; Lore Van Espen; Marisa Keller; Mads Israelsen; Tommi Suvitaival et al.
Source: check_circle
Crossref

Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease

Gut
2024-06 | Journal article
Contributors: Mads Israelsen; Camila Alvarez-Silva; Bjørn Stæhr Madsen; Camilla Dalby Hansen; Nikolaj Christian Torp; Stine Johansen; Johanne Kragh Hansen; Katrine Prier Lindvig; Jeanlouis Insonere; Virginie Riviere et al.
Source: check_circle
Crossref

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial

BMJ Open
2024-02 | Journal article
Contributors: Nikolaj Torp; Mads Israelsen; Minneke Coenraad; Maria Papp; Debbie Shawcross; Marko Korenjak; Paolo Angeli; Wim Laleman; Adria Juanola; Pere Gines et al.
Source: check_circle
Crossref

Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Annals of Internal Medicine
2023 | Journal article
EID:

2-s2.0-85146365348

Part of ISSN: 15393704 00034819
Contributors: Hansen, C.D.; Gram-Kampmann, E.-M.; Hansen, J.K.; Hugger, M.B.; Madsen, B.S.; Jensen, J.M.; Olesen, S.; Torp, N.; Rasmussen, D.N.; Kjærgaard, M. et al.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease

Liver International
2023-07 | Journal article
Contributors: Stine Johansen; Mads Israelsen; Ida F. Villesen; Nikolaj Torp; Mette J. Nielsen; Maria Kjærgaard; Katrine P. Lindvig; Camilla D. Hansen; Peter Andersen; Ditlev N. Rasmussen et al.
Source: check_circle
Crossref

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

BMC Public Health
2022 | Journal article
EID:

2-s2.0-85134389852

Part of ISSN: 14712458
Contributors: Graupera, I.; Thiele, M.; Ma, A.T.; Serra-Burriel, M.; Pich, J.; Fabrellas, N.; Caballeria, L.; de Knegt, R.J.; Grgurevic, I.; Reichert, M. et al.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis

Clinical Gastroenterology and Hepatology
2022-08 | Journal article
Contributors: Mads Israelsen; Helene Bæk Juel; Sönke Detlefsen; Bjørn Stæhr Madsen; Ditlev Nytoft Rasmussen; Trine R. Larsen; Maria Kjærgaard; Mary Jo Fernandes Jensen; Stefan Stender; Torben Hansen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Collagen proportionate area predicts long-term mortality in patients with alcoholic hepatitis

Digestive and Liver Disease
2022-05 | Journal article
Contributors: Mads Israelsen; Marta Guerrero Misas; Anastasios Koutsoumourakis; Andrew Hall; Claudia Covelli; Elena Buzzetti; Laura Iogna Prat; Davide Roccarina; Tu Vinh Luong; Alberto Quaglia et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Association of the liver and plasma lipidomes with the histological stage of alcohol-related liver disease

medRxiv
2021 | Other
EID:

2-s2.0-85113116415

Contributors: Thiele, M.; Suvitaival, T.; Trošt, K.; Kim, M.; de Zewadzki, A.; Kjaergaard, M.; Rasmussen, D.N.; Lindvig, K.P.; Israelsen, M.; Detlefsen, S. et al.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287] (JHEP Reports (2021) 3(3), (S258955592100063X), (10.1016/j.jhepr.2021.100287))

JHEP Reports
2021 | Journal article
EID:

2-s2.0-85123313427

Part of ISSN: 25895559
Contributors: Torp, N.; Israelsen, M.; Madsen, B.; Lutz, P.; Jansen, C.; Strassburg, C.; Mortensen, C.; Knudsen, A.W.; Sorensen, G.L.; Holmskov, U. et al.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3).

Liver international : official journal of the International Association for the Study of the Liver
2021-12-10 | Journal article
Contributors: Nikolaj Christian Torp; Israelsen M; Nielsen MJ; Åstrand CP; Juhl P; Stine Johansen; Hansen CD; Bjørn Madsen; Ida Falk Villesen; Diana Julie Leeming et al.
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Journal of Hepatology
2021-11 | Journal article
Contributors: Ditlev Nytoft Rasmussen; Maja Thiele; Stine Johansen; Maria Kjærgaard; Katrine Prier Lindvig; Mads Israelsen; Steen Antonsen; Sönke Detlefsen; Aleksander Krag; Ema Anastasiadou et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication

JHEP Reports
2021-06 | Journal article
Contributors: Mads Israelsen; Min Kim; Tommi Suvitaival; Bjørn Stæhr Madsen; Camilla Dalby Hansen; Nikolaj Torp; Kajetan Trost; Maja Thiele; Torben Hansen; Cristina Legido-Quigley et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.

JHEP reports : innovation in hepatology
2021-03-29 | Journal article | Author
Contributors: Nikolaj Christian Torp; Mads Israelsen; Madsen B; Lutz P; Jansen C; Strassburg C; Christian Mortensen; Knudsen AW; Sorensen GL; Holmskov U et al.
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 3)‎

Comprehensive lipidomics reveals reduced hepatic lipid turnover in NAFLD during alcohol intoxication

2021-02-19 | Other
Contributors: Mads Israelsen; Min Kim; Tommi Suvitaival; Bjørn Stæhr Madsen; Camilla Dalby Hansen; Nikolaj Torp; Kajetan Trost; Maja Thiele; Torben Hansen; Cristina Legido-Quigley et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Editorial: can quantitative fibrosis assessment be used to enhance prediction of outcomes in patients with alcohol-related liver disease? Authors' reply.

Alimentary pharmacology & therapeutics
2021-01-01 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 3)‎

Statiner er sikre ved leversygdom og har muligvis en gunstig effekt

Ugeskrift for Laeger
2020 | Journal article
EID:

2-s2.0-85126921095

Part of ISSN: 16036824 00415782
Contributors: Hugger, M.B.; Israelsen, M.; Hansen, C.D.; Krag, A.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease

Liver Transplantation
2020-12 | Journal article
Contributors: Olaf Tyc; Christian Jansen; Robert Schierwagen; Frank Erhard Uschner; Mads Israelsen; Sabine Klein; Cristina Ortiz; Christian P. Strassburg; Stefan Zeuzem; Wenyi Gu et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease.

Alimentary pharmacology & therapeutics
2020-10-12 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 3)‎

2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis.

Liver international : official journal of the International Association for the Study of the Liver
2020-04-08 | Journal article
Contributors: Maja Thiele; Mie Balle Hugger; Kim Y; Rautou PE; Elkrief L; Jansen C; Verlinden W; Allegretti G; Israelsen M; Horia Stefanescu et al.
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial

American Journal of Physiology-Gastrointestinal and Liver Physiology
2020-02-01 | Journal article
Contributors: Mads Israelsen; Emilie Kristine Dahl; Bjørn Stæhr Madsen; Signe Wiese; Flemming Bendtsen; Søren Møller; Annette Dam Fialla; Boye L. Jensen; Aleksander Krag
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Statins are safe in patients with liver diseases and may have a beneficial effect

Ugeskrift for laeger
2019 | Journal article
EID:

2-s2.0-85069288779

Part of ISSN: 16036824
Contributors: Hugger, M.B.; Israelsen, M.; Hansen, C.D.; Krag, A.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

[Statins are safe in patients with liver diseases and may have a beneficial effect].

Ugeskrift for laeger
2019-07-01 | Journal article
Contributors: Hugger MB; Israelsen M; Hansen CD; Krag A
Source: Self-asserted source
Mads Israelsen

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

Trials
2018 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Clinical aspects of alcoholic liver disease

The Human Gut-Liver-Axis in Health and Disease
2018 | Book chapter
EID:

2-s2.0-85078089335

Contributors: Israelsen, M.; Krag, A.; Thiele, M.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients

World Journal of Gastroenterology
2018 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Terlipressin versus other vasoactive drugs for hepatorenal syndrome

The Cochrane database of systematic reviews
2017 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome

The Cochrane database of systematic reviews
2017 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Acute kidney injury and hepatorenal syndrome in cirrhosis

Journal of gastroenterology and hepatology
2015 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 2)‎

Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis

Liver international : official journal of the International Association for the Study of the Liver
2015 | Journal article
Source: Self-asserted source
Mads Israelsen
grade
Preferred source (of 3)‎

Terlipressin versus other vasoactive drugs for hepatorenal syndrome

Cochrane Database of Systematic Reviews
2015 | Journal article
EID:

2-s2.0-85041801325

Part of ISSN: 1469493X
Contributors: Israelsen, M.; Krag, A.; Gluud, L.L.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

[Hepatorenal syndrome: diagnosis, treatment and prevention]

Ugeskrift for laeger
2013 | Journal article
Source: Self-asserted source
Mads Israelsen

Hepatorenalt syndrom: Diagnose, behandling og forebyggelse

Ugeskrift for Laeger
2013 | Journal article
EID:

2-s2.0-84878735942

Part of ISSN: 00415782
Contributors: Israelsen, M.E.; Gluud, L.L.; Bendtsen, F.; Møller, S.; Krag, A.
Source: Self-asserted source
Mads Israelsen via Scopus - Elsevier

The Human Gut-Liver-Axis in Health and Disease

Source: Self-asserted source
Mads Israelsen

Peer review (9 reviews for 5 publications/grants)

Review activity for BMJ open. (1)
Review activity for Clinical gastroenterology and hepatology (2)
Review activity for JHEP reports. (1)
Review activity for Journal of hepatology. (2)
Review activity for The Lancet. (3)